About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

DAIICHI SANKYO COMPANY, LIMITED(4568) Summary

4568
TSE Prime
DAIICHI SANKYO COMPANY, LIMITED
3,620.0
JPY
-12.0
(-0.33%)
Apr 4, 3:30 pm JST
24.78
USD
Apr 4, 2:30 am EDT
Result
PTS
outside of trading hours
3,560.1
Apr 4, 10:39 pm JST
Summary Chart Historical News Financial Result
PER
28.1
PBR
4.17
Yield
1.66%
Margin Trading Ratio
13.74
Stock Price
Apr 4, 2025
Opening Apr 4, 9:00 am
3,632.0 JPY 24.83 USD
Previous Close Apr 3
3,632.0 JPY 24.66 USD
High Apr 4, 9:38 am
3,790.0 JPY 25.95 USD
Low Apr 4, 3:30 pm
3,620.0 JPY 24.78 USD
Volume
10,748,100
Trading Value
0.04T JPY 0.27B USD
VWAP
3681.28 JPY 25.21 USD
Minimum Trading Value
362,000 JPY 2,478 USD
Market Cap
6.91T JPY 0.05T USD
Number of Trades
20,966
Liquidity & Number of Trades
As of Apr 4, 2025
Liquidity
High
1-Year Average
8,905
1-Year High Jan 20, 2025
26,017
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 28, 2025 85,900 2,784,400 32.41
Mar 21, 2025 210,400 2,893,100 13.75
Mar 14, 2025 169,300 3,131,200 18.49
Mar 7, 2025 243,700 3,266,200 13.40
Feb 28, 2025 83,200 3,671,100 44.12
Company Profile
DAIICHI SANKYO COMPANY, LIMITED is a major pharmaceutical company in Japan, with strengths in cardiovascular and infectious diseases. The company has partnered with AstraZeneca of the UK for new cancer drugs.
Sector
Pharmaceuticals
DAIICHI SANKYO COMPANY, LIMITED primarily engages in the research, development, manufacturing, and sales of pharmaceuticals, with a broad range of operations both domestically and internationally. In Japan, the company operates through multiple subsidiaries involved in pharmaceutical manufacturing, research and development and sales of over-the-counter drugs, and vaccine research, development, and production, showcasing a diverse group of companies with varied functions. The company has partnered with AstraZeneca in the oncology field. Internationally, DAIICHI SANKYO has subsidiaries in the United States, Europe, China, Brazil, and other regions, conducting pharmaceutical research, development, manufacturing, and sales in each area. In the United States, the company has established a holding company, while in Europe, it operates through numerous group companies across various countries. DAIICHI SANKYO leverages its global network for research, development, manufacturing, and sales to enhance its competitiveness in the world market.